Mira Pharmaceuticals (MIRA) Net Cash Flow (2022 - 2025)

Mira Pharmaceuticals has disclosed Net Cash Flow across 4 years of filings, most recently posting $3.7 million for Q4 2025.

• Net Cash Flow for Q4 2025 came in at $3.7 million, up 379.58% year-over-year; the trailing twelve-month figure through Dec 2025 was $3.5 million (up 296.41% YoY), and the FY2025 annual result was $3.5 million, up 296.41% from the prior year.
• Net Cash Flow came in at $3.7 million for Q4 2025 at Mira Pharmaceuticals, up from $1.9 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $5.8 million in Q3 2023 to a low of -$1.6 million in Q1 2025.
• The 4-year median for Net Cash Flow is -$412894.0 (2023), against an average of $391614.8.
• Across the five-year window, Net Cash Flow jumped 1015.1% in 2023 and sank 3102.96% in 2024, its largest moves.
• Mira Pharmaceuticals' Net Cash Flow stood at $163563.0 in 2022, then plunged by 873.87% to -$1.3 million in 2023, then dropped by 3.62% to -$1.3 million in 2024, then soared by 379.58% to $3.7 million in 2025.
• The last three Net Cash Flow figures came in at $3.7 million (Q4 2025), $1.9 million (Q3 2025), and -$476159.0 (Q2 2025), per Business Quant data.